Form 4: Bioventus Director John Bartholdson Increases Direct Stake Through RSU Vesting

Bioventus Inc. Director and 10% owner John A. Bartholdson has increased his direct beneficial ownership of Class A Common Stock by 7,575 shares following the vesting of Restricted Stock Units.

Summary

• John A. Bartholdson, a Director and 10% owner of Bioventus Inc. (BVS), acquired 7,575 shares of Class A Common Stock on June 6, 2025.
• The acquisition resulted from the vesting of 7,575 Restricted Stock Units (RSUs), with a transaction price of $0 per share, indicating a non-cash acquisition.
• Following this transaction, Mr. Bartholdson directly beneficially owns 79,620 shares of Class A Common Stock.
• Additionally, Mr. Bartholdson indirectly beneficially owns 6,939,357 shares of Class A Common Stock through various Juniper Entities, including Juniper Targeted Opportunity Fund, L.P., Juniper Targeted Opportunities, L.P., and Juniper Multi-Strategy Fund, L.P.
• Mr. Bartholdson, as a managing member of the general partners and investment manager of the Juniper Entities, shares voting and dispositive power over these indirectly held shares, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The document reports a routine insider transaction (RSU vesting) which increases the director's direct stake, generally viewed as a neutral to slightly positive event as it aligns insider interests with shareholders without indicating new strategic moves or financial performance.

Positives

• The vesting of Restricted Stock Units indicates a pre-planned compensation event, aligning management incentives with shareholder value.
• The increase in direct beneficial ownership by a director and 10% owner can be viewed as a positive sign of confidence in the company's future.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape within the medical device or orthobiologics sector.

Related Party Transactions

• John A. Bartholdson's indirect beneficial ownership of 6,939,357 shares is held through Juniper Entities (Juniper Targeted Opportunity Fund, L.P., Juniper Targeted Opportunities, L.P., and Juniper Multi-Strategy Fund, L.P.). As a managing member of the general partners and investment manager of these entities, he shares voting and dispositive power over these shares, representing a related party ownership structure.

Stakeholder Impact

• Shareholders: The increase in a director's direct ownership through RSU vesting can be seen as a positive signal of continued alignment between management and shareholder interests.

Key Dates

Keywords

Bioventus Inc., BVS, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU Vesting, John Bartholdson, Director, 10% Owner, Equity Compensation